Showing results (961-970 of 1,396) with videos related to
Sort By:
Pageof 140
JCO Precision Oncology|July 10, 2025
Cancer Testis Antigen Expression Correlates With Immune Activation and Survival in Small Bowel Neuroendocrine TumorsReed I Ayabe, Y David Seo, Brenda Melendez, et al.JCO Precision Oncology|July 9, 2025
Germline POT1 Variants in a Pan-Cancer CohortPamela L Brock, Morgan Webster, Sandya Liyanarachchi, et al.JCO Precision Oncology|July 25, 2025
Genomic Landscape and Clinical Relevance in Chinese Patients With Upper Tract Urothelial CarcinomaZhi Shang, Jian Pan, Shanshan Wang, et al.JCO Precision Oncology|July 23, 2025
Personalized N-of-1 Combination Therapies for Advanced Gastrointestinal Stromal TumorsSangkyu Noh, Ashwyn K Sharma, Paul T Fanta, et al.JCO Precision Oncology|August 6, 2025
Impact of BRCA Mutation on Treatment Outcomes of Endocrine Therapy ± CDK4/6 Inhibitors in Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor-2-Negative Breast Cancer: A Systematic Review and Meta-AnalysisHamdy A Azim, Hagar Elghazawy, Kyrillus S Shohdy, et al.JCO Precision Oncology|June 4, 2025
ORCHARD: Osimertinib Plus Necitumumab in Patients With Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With a Secondary Epidermal Growth Factor Receptor Alteration Whose Disease Had Progressed on First-Line OsimertinibJonathan W Riess, Adrianus J de Langen, Santiago Ponce, et al.JCO Precision Oncology|May 5, 2025
Personalized Circulating Tumor DNA Testing for Detection of Progression and Treatment Response Monitoring in Patients With Metastatic Invasive Lobular Carcinoma of the BreastJulia Foldi, Steffi Oesterreich, Antony Tin, et al.JCO Precision Oncology|May 5, 2025
Assessment of Circulating Tumor DNA Burden in Patients With Metastatic Gastric Cancer Using Real-World DataSenaka A Peter, Razvan Cristescu, Carol Peña, et al.JCO Precision Oncology|November 6, 2025
Genomic Landscape and Outcomes of Renal Cell Carcinoma With Metastases to the PancreasMichael J Glover, Arya Ashok, Osama Khan, et al.JCO Precision Oncology|October 9, 2025
Predictive Effectiveness of Circulating Tumor DNA in Recurrent Early-Stage Non-Small Cell Lung Cancer: An Updated Meta-AnalysisDi Lu, Nengke Lin, Shaobin Li, et al.Pageof 140